Oncotelic Therapeutics, Inc. ( OTLC) - Key Metrics
OTLC Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | $0 | $0 | $0 |
| 2026Q1 | $0 | $0 | $0 | $0 |
| 2025Q4 | $0 | $0.59 | $0 | $0 |
| 2025Q3 | $0 | $0 | $0 | $0 |
| 2025Q2 | $0 | $0 | $0 | $0 |
OTLC Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 12.19 |
| 2026Q1 | 0% | -2.03 |
| 2025Q4 | 0% | 0.03 |
| 2025Q3 | 0% | -7.70 |
| 2025Q2 | 0% | 15.84 |
OTLC
Price: $0.02
52 week price:
Earnings Per Share: -0.01 USD
P/E Ratio: -4
Exchange: OQB
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 9.6 million